Debut issue of Foot & Ankle ... ( An article in the debut issue of SAG...)

Debut issue of Foot & Ankle Specialist

Date:2/13/2008

An article in the debut issue of SAGEs Foot & Ankle Specialist (FAS,) written by Thomas Zgonis, DPM, FACFAS, John J. Stapleton, DPM, and Thomas S. Roukis, DPM, FACFAS, details a 3-step treatment plan for patients with diabetic foot infections, recommending first controlling the infection by removing the infected tissue, then conducting a comprehensive assessment, and finally, restructuring the tissue to assure that the wound is closed properly. Following this approach can help save the limb.

This type of article is essential to show how well we are able to incorporate different specialties and to help show a diverse approach to the treatment of a complicated problem, said Bob Baravarian, DPM, co-editor of FAS. This new journal will enable practitioners to address a broad range of disorders and provide their patients with the best current diagnosis and therapy.

FAS is edited by Bob Baravarian, DPM, chief of foot and ankle surgery at Santa Monica/UCLA Medical Center and Orthopedic Hospital, assistant clinical professor at the David Geffen School of Medicine at UCLA, and co-director of Los Angeles University Foot and Ankle Institute, along with Greg Berlet, MD, a board certified orthopedic surgeon who is Chief Section of Foot and Ankle, and a clinical assistant professor, Department of Orthopedics, Ohio State University. The new journal provides 11,000 foot and ankle caregivers the latest information in foot and ankle treatment by publishing research, reviews, technical perspectives, case studies, and other evidence-based articles.

'/>"/>

Contact: Andrea Rulfo
media.inquiries@sagepub.com
805-410-7150
SAGE Publications
Source:Eurekalert

1

GOOD

Post Your Comments:

(Date:12/4/2009)...4, 2009 New findings by UT Southwestern researche...mmune disorders might also help slow the destructi... diagnosed with insulin-dependent (type 1) diabete...nile diabetes, cells in the pancreas called beta c...utoimmune process. , Researchers at UT Southwest...

(Date:12/4/2009)... Tender Corp., a leading manufacturer of o...ts designed to enhance consumers’ quality of...e coveted American Podiatric Medical Association (...g cream, HealthiFeet®. , ...eading manufacturer of over-the-counter topical cr...

(Date:12/4/2009)... MINNEAPOLIS, Dec. 4 New data from...ericans struggled to get enough to eat at some poi...ans one in six Americans struggled with hunger. To...lls CEO Ken Powell, NBC,s The Biggest Loser,s Bob ... B. Escarra are teaming up to turn on the producti...

(Date:12/4/2009)...HOMA CITY, Dec. 4 PD-Rx ...nounced revenue of $5,012,334 for the first quarte...e same period last year. Operating income and net... respectively, each a 70% decrease over the same p...decrease in pharmacy sector sales. This trend is ...

(Date:12/4/2009)...r 4, 2009 -- Substantial progress has been made ov... ability to diagnose and treat epilepsy and its co...ment has not reached most of the 50 million people...ree million people in the United States who have t... M.D., president of the American Epilepsy Society ...

Breaking Medicine News(10 mins):Health News:FDA-approved drug may slow beta cell destruction in type 1 diabetes patients 2 Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2 Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3 Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4 Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 2 Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 3 Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 4 Health News:PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings 2 Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2 Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3 Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4

[0] FDA-approved drug may slow beta cell destruction in type 1 diabetes patients [0] Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval [0] General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger'[0] PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings [0] Epilepsy patients caught in treatment gap are not getting state-of-the-art care

...more often than biologists once thought. Cutting a...les into new structures is carried out by// the hu...e enhanced by this mechanism. This method could al...pe of protein required, an RNA template, produced ...

...nt on September 8 that treatment for a broad range...ten years. Researchers have found// treatments by ...gic reaction. These treatments harmlessly desensit...of Amsterdam, who is leading work on the developme...

... the hardness or elasticity of the liver has been ...c resonance imaging (MRI).// Initial tests show pr...for detecting liver fibrosis, a common condition t...volve complications and may be inaccurate due to s...

...eterious effect on young, developing brains, accor...at obesity in toddlers is linked to lower IQ score...with metabolic problems like diabetes, high choles...postulating that early-onset morbid obesity and th...

...m Children's Hospital Boston and the University of...ho must stay awake// all night may be able to put ...xide levels building up in the brain. Previous res... issue of the Journal of Neurochemistry and the Se...

...ing to get regular mammograms doe because of inacc...s.// Breast Cancer Aotearoa Coalition Deputy...rcent of the eligible women have taken the offer f...t for early detection of breast abnormalities incl...

Other Medicine News:Health News:'Mix and match' of proteins may have a significant role in immunity 2 Health News:Cure for food allergies is less than a decade away 2 Health News:MRI Development Yields Breakthrough in Diagnosis of Liver Fibrosis 2 Health News:Obesity Takes its Toll on IQ of Toddlers 2 Health News:Nitric Oxide Levels In Brain Indicate Sleep 2

'Mix and match' of proteins may have a significant role in immunity Cure for food allergies is less than a decade away MRI Development Yields Breakthrough in Diagnosis of Liver Fibrosis Obesity Takes its Toll on IQ of Toddlers Nitric Oxide Levels In Brain Indicate Sleep Women Do Not Have Access To Free Mammograms

(Date:12/3/2009)..., SUNNYVALE, Calif., Dec. 3 /PRNewswire-FirstCall...armaceutical company focused on developing and com...he treatment of immune mediated diseases and cance... conference call on, Tuesday, December 8, 2009 at ...0am Pacific Time) to discuss clinical data regardi...

(Date:12/3/2009)... , HOERSHOLM, Denmark and SAN DIEGO, Ca...SPC3649 Successfully Inhibits miR-122, a microRNA ...by Significantly Reducing Hepatitis C,Virus in the...ith the,Hepatitis C Virus , - SPC3649 Dem...tance and,No Serious Adverse Events in the Treated...

(Date:12/3/2009)..., NASHVILLE, Tenn., Dec. 3 /PRNewswire-FirstCal...CPIX ) announced today that data from a recent cli...tion, an intravenous treatment for pain and fever,... Health-System Pharmacists (ASHP) Midyear Clinical... The new data will be displayed in a poster presen...

Breaking Medicine Technology:Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2 New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2 New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3 New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4 New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5 New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 2 New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 3 Improved Endo Capsule Software enhances diagnostic experience 10493 1 Improved Endo Capsule Software enhances diagnostic experience 10493 2 Cocoa in Chocolate May Be Good for the Heart 59974 1 Cocoa in Chocolate May Be Good for the Heart 59974 2 Cocoa in Chocolate May Be Good for the Heart 59974 3 Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 59970 1 Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 59970 2 Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 59970 3

[0] Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 [0] New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C [0] New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting

...lizing,single-use bioprocessing for development an... today that it has completed a product fill under ... Trius Therapeutics Phase I,clinical trial., "We ...his GMP fill,project, an effort that we were able ...eadline," said Leigh N. Pierce, president of Pacif...

...ension,s Twenty-Third Annual...ercent (45%) of patients with stage 1, hypertensi...n medoxomil), and BENICAR HCT(R) (olmesartan med...ormotension (< 120/80 mm Hg) (placebo:1.4%)., ...tage 1 hypertension were, able to reach a goal blo...

Other Medicine Technology:PacificGMP Completes GMP Product Fill for Trius Therapeutics 2 New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 2 New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 3 New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 4 New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 5 New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 6 New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 7

PacificGMP Completes GMP Product Fill for Trius Therapeutics New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)

Automatic Blood Pressure Monitor

FreeStyle Freedom Blood Glucose Monitoring System

REAL-Time Continuous Glucose Monitoring

Monitect Multiple Drug Screen Cassette Test

Medicine Products:

Automatic Blood Pressure Monitor FreeStyle Freedom Blood Glucose Monitoring System REAL-Time Continuous Glucose Monitoring Monitect Multiple Drug Screen Cassette Test

Debut issue of Foot & Ankle ...( An article in the debut issue of SAG...),Health